Anti-Rejection Drug May Boost Diabetes in Kidney Transplant Patients (HealthDay)

[riky]

Anti-Rejection Drug May Boost Diabetes in Kidney Transplant
Patients
    (HealthDay)

 

HealthDay - THURSDAY, May 29 (HealthDay News) -- Treatment with the
anti-rejection drug sirolimus may lead to increased risk of diabetes in
kidney transplant patients, say researchers who analyzed data on about
20,000 Medicare patients who had kidney transplants between 1995 and
2003.


You are not allowed to view links. Register or Login/news.yahoo.com/s/hsn/20080530/hl_hsn/antirejectiondrugmayboostdiabetesinkidneytransplantpatients